Variability in mRNA expression of ABC- and SLC-transporters in human intestinal cells: Comparison between human segments and Caco-2 cells

European Journal of Pharmaceutical Sciences

Volumn 28, Issue 4, 2006, Pages 291-299

  Seithel, Annick ^a   Karlsson, Johan ^a   Hilgendorf, Constanze ^a   Björquist, Anna ^a   Ungell, Anna Lena ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

Absorption; Caco 2 cells; Human intestine; Membrane Transport proteins; Real time PCR

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; MESSENGER RNA; MONOCARBOXYLATE TRANSPORTER; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; OCTAMER TRANSCRIPTION FACTOR 1; OCTAMER TRANSCRIPTION FACTOR 2; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 2; ORGANIC ANION TRANSPORTER 3; ORGANIC CATION TRANSPORTER; PEPTIDE TRANSPORTER 1; PRIMER DNA;

ARTICLE; COLON; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; INTESTINE CELL; JEJUNUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; QUALITY CONTROL; REAL TIME POLYMERASE CHAIN REACTION;

ATP-BINDING CASSETTE TRANSPORTERS; CACO-2 CELLS; COLON; GENE EXPRESSION REGULATION; HUMANS; INTESTINAL MUCOSA; JEJUNUM; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; ORGANIC ANION TRANSPORTERS; P-GLYCOPROTEIN; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS;

EID: 33747090656     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2006.03.003     Document Type: Article

References (38)

1. Abe T., Unno M., Onogawa T., Tokui T., Kondo T., Nakagomi R., Adachi H., Fujiwara K., Okabe M., Suzuki T., Nunoki K., Sato E., Kakyo M., Nishio T., Sugita J., Asano N., Tanemoto M., Seki M., Date F., Ono K., Kondo Y., Shiiba K., Suzuki M., Ohtani H., Shimosegawa T., Iinuma K., Nagura H., Ito S., and Matsuno S. LST-2, A human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterology 120 (2001) 1699
2. Anderle P., Niederer E., Rubas W., Hilgendorf C., Spahn-Langguth H., Wunderli-Allenspach H., Merkle H., and Langguth P. P-glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels. J. Pharm. Sci. 87 (1998) 757-762
3. Anderle P., Rakhmanova V., Woodford K., Zerangue N., and Sadee W. Messenger RNA expression of transporter and ion channel genes in undifferentiated and differentiated Caco-2 cells compared to human intestines. Pharm. Res. 20 (2003) 3-15
4. Anderle P., Huang Y., and Sadee W. Intestinal membrane transport of drugs and nutrients: genomics of membrane transporters using expression microarrays. Eur. J. Pharm. Sci. 21 (2004) 24
5. Applied-Biosystems, 1997. Relative Quantification of Gene Expression User Bulletin #2: ABI PRISM 7700 Sequence Detection System.
6. Artursson P., and Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 175 (1991) 880-885
7. Behrens I., and Kissel T. Do cell culture conditions influence carrier-mediated transport of peptides in Caco-2 cell monolayers?. Eur. J. Pharm. Sci. 19 (2003) 433-442
8. Behrens I., Kamm W., Dantzig A.H., and Kissel T. Variation of peptide transporter (PepT1 and HPT1) expression in Caco-2 cells as a function of cell origin. J. Pharm. Sci. 93 (2004) 1743-1754
9. Bleasby K., Chauhan S., and Brown C.D.A. Characterization of MPP+ secretion across human intestinal Caco-2 cell monolayers: role of P-glycoprotein and a novel Na+-dependent organic cation transport mechanism. Br. J. Pharmacol. 129 (2000) 619-625
10. Borst P., Evers R., Kool M., and Wijnholds J. The multidrug resistance protein family. Biochim. Biophys. Acta 1461 (1999) 357
11. Borst P., Evers R., Kool M., and Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J. Natl. Cancer Inst. 92 (2000) 1295-1302
12. Borst P., and Elferink O.R. Mammalian ABC transporters in health and disease. Annu. Rev. Biochem. 71 (2002) 537-592
13. Chan L.M., Lowes S., and Hirst B.H. The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur. J. Pharm. Sci. 21 (2004) 25-51
14. Dietrich C.G., Geier A., and Oude Elferink R.P.J. ABC of oral bioavailability: transporters as gatekeepers in the gut. Gut 52 (2003) 1788-1795
15. Giulietti A., Overbergh L., Valckx D., Decallonne B., Bouillon R., and Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25 (2001) 401
16. Hagenbuch B., and Meier P.J. The superfamily of organic anion transporting polypeptides. Biochim. Biophys. Acta 1609 (2003) 1-18
17. Hayer-Zillgen M., Bruss M., and Bonisch H. Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3. Br. J. Pharmacol. 136 (2002) 836
18. Herrera-Ruiz D., Wang Q., Gudmundsson O.S., Cook T.J., Smith R.L., Faria T.N., and Knipp G.T. Spatial expression patterns of peptide transporters in the human and rat gastrointestinal tracts, Caco-2 in vitro cell culture model, and multiple human tissues. AAPS Pharm. Sci. 3 (2001) E9
19. Hunter J., Jepson M.A., Tsuruo T., Simmons N.L., and Hirst B.H. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators. J. Biol. Chem. 268 (1993) 14991-14997
20. Kerns E.H., Di L., Petusky S., Farris M., Ley R., and Jupp P. Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery. J. Pharm. Sci. 93 (2004) 1440-1453
21. Kullak-Ublick G., Ismair M., Stieger B., Landmann L., Huber R., Pizzagalli F., Fattinger K., Meier P., and Hagenbuch B. Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology 120 (2001) 533
22. Langmann T., Mauerer R., Zahn A., Moehle C., Probst M., Stremmel W., and Schmitz G. Real-time reverse transcription-PCR expression profiling of the complete human ATP-binding cassette transporter superfamily in various tissues. Clin. Chem. 49 (2003) 230-238
23. Li Q., Sai Y., Kato Y., Tamai I., and Tsuji A. Influence of drugs and nutrients on transporter gene expression levels in Caco-2 and LS180 intestinal epithelial cell lines. Pharm. Res. 20 (2003) 1124
24. +/peptide cotransporter. J. Biol. Chem. 270 (1995) 6456-6463
25. Maliepaard M., Scheffer G.L., Faneyte I.F., van Gastelen M.A., Pijnenborg A.C., Schinkel A.H., van De Vijver M.J., Scheper R.J., and Schellens J.H. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 61 (2001) 3458-3464
26. Martel F., Grundemann D., Calhau C., and Schömig E. Apical uptake of organic cations by human intestinal Caco-2 cells: putative involvement of ASF transporters. Naunyn Schmiedebergs Arch. Pharmacol. 363 (2001) 40-49
27. Nakamura T., Sakaeda T., Ohmoto N., Tamura T., Aoyama N., Shirakawa T., Kamigaki T., Nakamura T., Kim K.I., Kim S.R., Kuroda Y., Matsuo M., Kasuga M., and Okumura K. Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas. Drug Metab. Dispos. 30 (2002) 4-6
28. Pan X., Terada T., Irie M., Saito H., and Inui K.-I. Diurnal rhythm of H+-peptide cotransporter in rat small intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 283 (2002) G57-G64
29. Pfrunder A., Gutmann H., Beglinger C., and Drewe J. Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines. J. Pharm. Pharmacol. 55 (2003) 59-66
30. Radonic A., Thulke S., Mackay I.M., Landt O., Siegert W., and Nitsche A. Guideline to reference gene selection for quantitative real-time PCR. Biochem. Biophys. Res. Commun. 313 (2004) 862
31. Stephens R.H., O'Neill C.A., Warhurst A., Carlson G.L., Rowland M., and Warhurst G. Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia. J. Pharmacol. Exp. Ther. 296 (2001) 584-591
32. Sun D., Lennernas H., Welage L.S., Barnett J.L., Landowski C.P., Foster D., Fleisher D., Lee K.D., and Amidon G.L. Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs. Pharm. Res. 19 (2002) 1400-1416
33. Taipalensuu J., Tornblom H., Lindberg G., Einarsson C., Sjoqvist F., Melhus H., Garberg P., Sjostrom B., Lundgren B., and Artursson P. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J. Pharmacol. Exp. Ther. 299 (2001) 164-170
34. Taipalensuu J., Tavelin S., Lazorova L., Svensson A.-C., and Artursson P. Exploring the quantitative relationship between the level of MDR1 transcript, protein and function using digoxin as a marker of MDR1-dependent drug efflux activity. Eur. J. Pharm. Sci. 21 (2004) 75
35. Ungell A.-L., and Karlsson J. Cell cultures in drug discovery: an industrial perspective. In: van de Waterbeemd H., Lennernas H., and Artursson P. (Eds). Drug Bioavailability. Estimation of Solubility, Permeability, Absorption and Bioavailability (2003), Wiley-VCH Verlag GmbH & Co KGaA, Weinheim 90-131
36. Walter E., and Kissel T. Heterogeneity in the human intestinal cell line Caco-2 leads to differences in transepithelial transport. Eur. J. Pharm. Sci. 3 (1995) 230
37. Wang T., and Brown M.J. mRNA quantification by real time TaqMan polymerase chain reaction: validation and comparison with RNase protection. Anal. Biochem. 269 (1999) 201
38. Zimmermann C., Gutmann H., Hruz P., Gutzwiller J.P., Beglinger C., and Drewe J. Mapping of multidrug resistance gene 1 and multidrug resistance-associated protein isoform 1 to 5 mRNA expression along the human intestinal tract. Drug Metab. Dispos. 33 (2005) 219-224